USD 25.72
(1.94%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 119.63 Million USD | 44.55% |
2023 | 82.23 Million USD | 6.53% |
2022 | 77.19 Million USD | 21.84% |
2021 | 63.36 Million USD | 11.37% |
2020 | 56.89 Million USD | -78.95% |
2019 | 270.23 Million USD | 20.2% |
2018 | 224.81 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q4 | 119.63 Million USD | 8.71% |
2024 Q1 | 90.24 Million USD | 9.73% |
2024 Q2 | 93.42 Million USD | 3.53% |
2024 FY | 119.63 Million USD | 45.48% |
2024 Q3 | 110.04 Million USD | 17.8% |
2023 Q1 | 77.87 Million USD | 0.88% |
2023 FY | 82.23 Million USD | 6.53% |
2023 Q4 | 82.23 Million USD | 6.87% |
2023 Q3 | 76.94 Million USD | -0.74% |
2023 Q2 | 77.52 Million USD | -0.45% |
2022 Q4 | 77.19 Million USD | 8.41% |
2022 Q2 | 64.66 Million USD | 11.62% |
2022 FY | 77.19 Million USD | 21.84% |
2022 Q3 | 71.2 Million USD | 10.12% |
2022 Q1 | 57.92 Million USD | -8.57% |
2021 Q3 | 68.37 Million USD | 9.22% |
2021 Q1 | 61.38 Million USD | 7.9% |
2021 FY | 63.36 Million USD | 11.37% |
2021 Q4 | 63.36 Million USD | -7.33% |
2021 Q2 | 62.6 Million USD | 1.98% |
2020 Q4 | 56.89 Million USD | 6.51% |
2020 FY | 56.89 Million USD | -78.95% |
2020 Q3 | 53.41 Million USD | -11.17% |
2020 Q2 | 60.13 Million USD | -30.76% |
2020 Q1 | 86.85 Million USD | -67.86% |
2019 Q4 | 270.23 Million USD | 0.0% |
2019 FY | 270.23 Million USD | 20.2% |
2019 Q1 | - USD | 0.0% |
2018 FY | 224.81 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Well Corporation | 109.51 Million USD | -9.238% |
Doximity, Inc. | 177.97 Million USD | 32.78% |
Evolent Health, Inc. | 1.61 Billion USD | 92.581% |
MultiPlan Corporation | 5.39 Billion USD | 97.783% |
Teladoc Health, Inc. | 2.06 Billion USD | 94.21% |
Veeva Systems Inc. | 1.26 Billion USD | 90.551% |